AKH Signature
Recovery· AKH Signature
In stockGLOW
GHK-cu 50mg, BPC-157 10mg, TB-500 10mg blend
Glow 70 is a 70mg lyophilised blend of GHK-Cu 50mg, BPC-157 10mg and TB-500 10mg for laboratory research. Price is shown in your currency, and its Certificate from a named outside laboratory is published on this page. Not for human or veterinary use.
Size70mgPurity99.87%
An AKH BioLabs exclusive three-peptide research blend of GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg), 70mg per vial. Each compound is studied individually for extracellular matrix synthesis, tissue repair or cell migration; the blend allows researchers to investigate how these pathways interact in a single reconstitution.
€80
Quantity
HPLC verified
9–14 day shipping
Full COA
Worldwide delivery
About this compound
The research profile.
GLOW Blend is a proprietary 70 mg lyophilised research blend formulated for skin and general wellness research models. Its composition is not published: the constituent list and ratios are held as proprietary formulation data and are available on request to verified research accounts. Nothing on this page should be read as identifying or implying any particular component.
The research context for blends of this type is the broader literature on peptides in dermal and cosmeceutical research, which groups the studied molecules by function — signalling peptides that interact with matrix synthesis pathways, carrier peptides, enzyme-inhibitor peptides, and neurotransmitter-inhibitor peptides. Review work in that field stresses that formulation, stability, and delivery route influence outcomes as much as the molecules themselves.
Because the blend is supplied as a single combined mass, all preparation and calculator figures on this page describe total blend material per vial. Per-component amounts are not published, and no claim is made here about the activity of any individual constituent.
For research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any condition.
Categorised as Recovery — Peptides studied in tissue-repair and inflammation models.
Dosing at a glance
What the literature reports.
For research and laboratory use only. Not for human consumption.
Route
Subcutaneous
Frequency
Once daily (study convention)
Reported range
3–8 mg
Protocol duration
4–8 weeks
3 mgcombined blend mass per administration8 mg
Figures describe total blend material per administration only. AKH BioLabs does not publish per-component amounts for this blend, and the peptide-in-skin literature cited here reports single molecules rather than proprietary combinations — so no study result should be read as characterising this vial.
Ranges reflect protocols reported in the published literature on GLOW Blend — see research citations.
Calculate a dilutionReconstitution & storage
From powder to solution.
- Step 01
Add 3 ml bacteriostatic water
Aim the stream at the vial wall rather than the powder.
- Step 02
Swirl gently — never shake
Rotate the vial until the solution runs clear. Agitation degrades the peptide.
- Step 03
Refrigerate at 2–8 °C
Reconstituted vials belong in the fridge, protected from direct light.
- Step 04
Use within 28 days
Discard any remainder once the stability window closes.
Lyophilised · −20 °CReconstituted · 2–8 °C, 28 days
A 70 mg vial in 3 ml gives roughly 23.3 mg/ml of combined blend material. Refrigerate at 2–8 °C and protect from light.
Reconstitution calculator
70 mg vialmg
ml
mg
5 mg = 5000 mcg
Draw
21.4units · U-100 insulin syringe
- Concentration
- 23.33 mg/ml
- Draws per vial
- 14
- Cost per draw
- €5.71
For research and laboratory use only. Not for human consumption.
Laboratory arithmetic for GLOW — enter the COA-verified vial content for exact figures. Not medical advice.
Effect timeline
Observed across the research window.
Milestones summarise findings reported in the cited studies. Outcomes vary across models and protocols.
Start
Preparation and handling
Review literature on peptide formulations notes that stability and delivery conditions influence experimental outcomes as much as the molecules studied, which is why handling is recorded from the first day of a protocol.
Week 2
Early observation window
Studies of peptides in dermal research models generally report their first measurable changes across the first fortnight, with instrument-based measures rather than subjective assessment.
Week 4
Mid-protocol assessment
Reviews of synthetic peptides in skin research describe four weeks as a common interim assessment point in the published study designs.
Week 8
Protocol end points
Most published peptide studies in this field conclude between eight and twelve weeks, where treated and control conditions are compared.
For research and laboratory use only. Not for human consumption.
Scientific research
The published evidence.
The dosing ranges and timeline milestones on this page summarise the peer-reviewed publications below.
References
- 01
Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci (2009). PubMed · 19570099
- 02
Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem (2020). PubMed · 33195061
- 03
Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel) (2021). PubMed · 34451799
Laboratory verification
One Certificate, published unaltered.
The Certificate is a test report from a named laboratory outside AKH, ordered by our manufacturer and shown here exactly as the laboratory issued it. A printed copy ships in every parcel.
- Batch
- 26144
- Test date
- 23 Jul 2026
- Task ID
- #1812440
- Purity
- 99.87%
Results
Glow(TB+BPC-157+GHK): 70mg | Purity: 99.87%
Verified by Brown Institute of Biomolecular Research. Scan the full report for every measurement.
Product FAQ
Questions researchers ask.
Pairs well with
Frequently co-studied.
Compounds that appear alongside GLOW in the research literature.
For research and laboratory use only. Not for human consumption.
Recovery
